As of 2025-07-01, the Relative Valuation of Ionis Pharmaceuticals Inc (IONS) is (33.02) USD. This relative valuation is based on P/E multiples. With the latest stock price at 39.94 USD, the upside of Ionis Pharmaceuticals Inc based on Relative Valuation is -182.7%.
The range of the Relative Valuation is (32.58) - (32.52) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.3x - 12.9x | 12.1x |
| Forward P/E multiples | 10.4x - 11.3x | 10.8x |
| Fair Price | (32.58) - (32.52) | (33.02) |
| Upside | -181.6% - -181.4% | -182.7% |
| Date | P/E |
| 2025-06-27 | -13.83 |
| 2025-06-26 | -13.82 |
| 2025-06-25 | -13.90 |
| 2025-06-24 | -13.77 |
| 2025-06-23 | -13.09 |
| 2025-06-20 | -13.00 |
| 2025-06-18 | -12.86 |
| 2025-06-17 | -12.56 |
| 2025-06-16 | -12.25 |
| 2025-06-13 | -12.37 |
| 2025-06-12 | -12.38 |
| 2025-06-11 | -12.58 |
| 2025-06-10 | -12.80 |
| 2025-06-09 | -12.77 |
| 2025-06-06 | -12.26 |
| 2025-06-05 | -12.25 |
| 2025-06-04 | -12.20 |
| 2025-06-03 | -12.08 |
| 2025-06-02 | -11.85 |
| 2025-05-30 | -11.64 |
| 2025-05-29 | -11.63 |
| 2025-05-28 | -11.27 |
| 2025-05-27 | -11.58 |
| 2025-05-23 | -11.46 |
| 2025-05-22 | -11.56 |
| 2025-05-21 | -11.64 |
| 2025-05-20 | -11.98 |
| 2025-05-19 | -11.82 |
| 2025-05-16 | -11.66 |
| 2025-05-15 | -11.46 |
| 2025-05-14 | -11.33 |
| 2025-05-13 | -11.30 |
| 2025-05-12 | -11.65 |
| 2025-05-09 | -11.21 |
| 2025-05-08 | -11.38 |
| 2025-05-07 | -11.49 |
| 2025-05-06 | -11.07 |
| 2025-05-05 | -11.69 |
| 2025-05-02 | -11.39 |
| 2025-05-01 | -11.02 |
| 2025-04-30 | -10.67 |
| 2025-04-29 | -10.36 |
| 2025-04-28 | -10.33 |
| 2025-04-25 | -10.32 |
| 2025-04-24 | -10.28 |
| 2025-04-23 | -10.11 |
| 2025-04-22 | -10.09 |
| 2025-04-21 | -9.91 |
| 2025-04-17 | -9.87 |
| 2025-04-16 | -9.85 |